Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD BACTEC™ Myco/F Lytic Culture Vials

K-Number: K222559 · 2023-03-24

Decision Date2023-03-24
Product CodeMDB
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BD BACTEC™ Myco/F Lytic Culture Vials is a medical device manufactured by Becton, Dickinson and Company. It received FDA 510(k) clearance on 2023-03-24 under approval number K222559. The device is classified under product code MDB. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD BACTEC™ Myco/F Lytic Culture Vials?

BD BACTEC™ Myco/F Lytic Culture Vials is a medical device that received FDA 510(k) clearance on 2023-03-24. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K222559.

When was BD BACTEC™ Myco/F Lytic Culture Vials approved by the FDA?

BD BACTEC™ Myco/F Lytic Culture Vials received FDA 510(k) clearance on 2023-03-24, under approval number K222559.

What company makes BD BACTEC™ Myco/F Lytic Culture Vials?

BD BACTEC™ Myco/F Lytic Culture Vials is manufactured by Becton, Dickinson and Company.

What is the FDA product code for BD BACTEC™ Myco/F Lytic Culture Vials?

The FDA product code for BD BACTEC™ Myco/F Lytic Culture Vials is MDB.

Related PubMed Literature

Other Devices by Becton, Dickinson and Company

View all 100 devices →

Related Devices (Code: MDB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.